THE FIRST METABOLIC
LIFESTYLE THERAPY
Metabolic drug therapies like Ozempic, Wegovy, Munjaro are becoming hugely popular. But without a metabolic lifestyle approach, results are good only as long as you take the medication. We're changing that with prevention and treatment of diseases related to metabolic health like diabetes, obesity and more.
LEARN MORETHE PROBLEM
Medications for weight loss like Ozempic, Wegovy and Munjaro are effective at weight loss. But there's a few catches.

39% OF MASS LOST
IS MUSCLE MASS
Up to 39% of weight loss comes from lean mass. This reduces calorie burning potential of the patient.

68% OF WEIGHT IS REGAINED
Participants regained two-thirds of their prior weight loss, with similar changes in cardiometabolic variables.

INCREASE IN INSULIN RESISTANCE
People who need to lose weight are already more insulin resistant. GLP-1s increase production of insulin, which will worsen their insulin resistance.

HUNGER HORMONES ARE SUPPRESSED
Many people find it physically hard to eat 1200 calories, and coming off of it those hormones come back.
WEIGHT REGAIN DATA
In studies looking at 1 year after GLP-1 Agonists are stopped all improvements in cardiometabolic health disappeared after 1 year of being off the drug

THE SOLUTION
BioCoach is metabolic lifestyle therapy that offers both prevention and treatment of metabolic disease.

RETAIN MUSCLE MASS
Maintained muscle means that you burn more calories both at rest and during exercise. In our pilot, 27% of people gained muscle

GLP-1 SPECIFIC
LIFESTYLE COACHING
Learn how to make long term sustainable changes with a tech enabled coaching platform.

DECREASE INSULIN RESISTANCE
People who follow a metabolic approach can improve their insulin resistance both while they’re on the drug and when they come off.

HUNGER HORMONES ARE SUPPRESSED
Suppress the increase in hunger hormones that happens you come off a GLP-1.
REACH OUT
Shoot our team a message and we'll get back to you right away.
REQUEST INFORMATION
Enter your information and our team will reach out.